---
figid: PMC8894711__fcimb-12-847539-g002
figtitle: Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis
  B Viral Infection
organisms:
- Hepatitis B virus
- Adenoviridae
- Human alphaherpesvirus 1
- Woodchuck hepatitis virus
- Stealth virus 1
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Curcuma longa
- Agaricus bisporus
- Pan troglodytes
- Macaca fascicularis
- Ophiocordyceps sinensis
- Marmota monax
- Salmonella enterica subsp. enterica serovar Typhimurium
- NA
organisms_ner:
- Mus musculus
- Pan troglodytes
- Rattus norvegicus
- Macaca fascicularis
- Marmota monax
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8894711
filename: fcimb-12-847539-g002.jpg
figlink: /pmc/articles/PMC8894711/figure/f2/
number: F2
caption: The interaction between HBV replication and the cellular signaling pathways.
  HBV infection activates downstream RIG-I-like, Wnt/β-catenin, TGF-β, GAS-STING signaling
  pathways, PI3K/AKT, JAK/STAT, RAS/MEK/ERK, promotes the secretion of antiviral cytokines
  (IFN-α, IFN-β) and inflammatory cytokines (IL-1, IL-6) inhibits the production of
  HBV cccDNA, and transcription assembly of viruses inhibits tumor growth. However,
  HBxAg can activate certain cellular signaling pathways and promote HBV replication.
  HBV replication inhibits apoptosis, differentiation, and transformation and is closely
  related to tumorigenesis.
papertitle: Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis
  B Viral Infection.
reftext: Yan Yan, et al. Front Cell Infect Microbiol. 2022;12:847539.
year: '2022'
doi: 10.3389/fcimb.2022.847539
journal_title: Frontiers in Cellular and Infection Microbiology
journal_nlm_ta: Front Cell Infect Microbiol
publisher_name: Frontiers Media S.A.
keywords: HBV | infection | TLR | signaling pathway | carcinogenesis | therapeutics
automl_pathway: 0.9287485
figid_alias: PMC8894711__F2
figtype: Figure
redirect_from: /figures/PMC8894711__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8894711__fcimb-12-847539-g002.html
  '@type': Dataset
  description: The interaction between HBV replication and the cellular signaling
    pathways. HBV infection activates downstream RIG-I-like, Wnt/β-catenin, TGF-β,
    GAS-STING signaling pathways, PI3K/AKT, JAK/STAT, RAS/MEK/ERK, promotes the secretion
    of antiviral cytokines (IFN-α, IFN-β) and inflammatory cytokines (IL-1, IL-6)
    inhibits the production of HBV cccDNA, and transcription assembly of viruses inhibits
    tumor growth. However, HBxAg can activate certain cellular signaling pathways
    and promote HBV replication. HBV replication inhibits apoptosis, differentiation,
    and transformation and is closely related to tumorigenesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ctnnb1
  - Tgfb1
  - Ltbp1
  - Ddx41
  - Stat2
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Pik3r1
  - Cgas
  - Sting1
  - Il6
  - Ifna
  - Ifnb1
  - Il1
  - Mdk
  - Zhx2
  - Mapk3
  - Mapk1
  - Nfkb1
  - Ccnd1
  - Jun
  - Myc
  - Nol3
  - CTNNB1
  - STAT2
  - CGAS
  - IL6
  - MAP2K1
  - CCND1
  - JUN
  - MYC
  - Wnt2
  - Pik3cg
  - STING1
  - IFNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TGFB1
  - TGFB2
  - TGFB3
  - DDX41
  - TRIM63
  - ERVK-9
  - ERVK-11
  - ERVK-19
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IFNA1
  - IL1B
  - MAP2K7
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK3
  - MAPK1
  - NFKB1
  - FOS
  - FOSB
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - Wnt5
  - Wnt4
  - wg
  - arm
  - dpp
  - gbb
  - put
  - mav
  - abs
  - Irp-1B
  - Irp-1A
  - Ras64B
  - Ras85D
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Sting
  - aub
  - JIL-1
  - Dsor1
  - Mtk
  - Raf
  - rl
  - Dif
  - dl
  - Rel
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - AP-1gamma
  - Jra
  - kay
---
